U.S. President Donald Trump looked set to open a new front in his trade wars on Monday with a plan to end preferential trade treatment for India that allows duty-free entry for $5.6 billion worth of the country’s exports to the United States.
Trump, who has vowed to cut U.S. trade deficits, has repeatedly called out India for its high tariffs, and U.S. trade officials said scrapping the concessions would take at least 60 days after notifications to Congress and the Indian government.
“I am taking this step because, after intensive engagement between the United States and the government of India, I have determined that India has not assured the United States that it will provide equitable and reasonable access to the markets of India,” Trump said in a letter to congressional leaders.
India is the world’s largest beneficiary of the GSP program and ending its participation would be the strongest punitive action for the South Asian nation since Trump took office in 2017.
The U.S. Trade Representative’s Office said removing India from the Generalized System of Preferences (GSP) program would not take effect for at least 60 days after the notifications, and would be done through a presidential proclamation.
The preferential trade treatment brings “actual benefit” of just $250 million a year to India, however, a government source said in the capital, New Delhi, adding that it hoped the planned withdrawal would not lead to trade hurdles.
“GSP is more symbolic of the strategic relationship, not in value terms,” added the source, who declined to be identified ahead of a news briefing by the Indian trade ministry.
It was not immediately clear what retaliatory action authorities in India, which is due to hold general elections this year, would take.
Trade ties with the United States were hurt after India unveiled new rules on e-commerce limiting the way internet retail giants Amazon.com Inc and Walmart Inc-backed Flipkart do business.
The e-commerce rules followed a drive by New Delhi to force global card payments companies such as Mastercard Inc and Visa Inc to move their data to India and higher tariffs on electronic products and smartphones.
“India has implemented a wide array of trade barriers that create serious negative effects on United States commerce,” the USTR said.
“Despite intensive engagement, India has failed to take the necessary steps to meet the GSP criterion.”
India’s top GSP exports to the United States in 2017 included motor vehicle parts, ferro alloys, precious metal jewelry, building stone, insulated cables and wires, said business grouping the Confederation of Indian Industry, which had lobbied against the withdrawal of preferential treatment.
Most of the exports were intermediate goods not produced in the United States because they are low in the manufacturing value chain, it added.
The U.S. goods and services trade deficit with India was $27.3 billion in 2017, the U.S. Trade Representative’s Office said.
Reporting by Eric Beech; Additional reporting by Neha Dasgupta in NEW DELHI; Editing by Sanjeev Miglani and Clarence Fernandez
Trump delivers dangerously false medical claim: Children are ‘virtually immune’ from coronavirus — which is ‘going away’
President Donald Trump is making dangerously false medical claims once again, this time to advance his agenda of forcing the nation's schools to re-open despite the coronavirus pandemic, which is growing worse in many parts of the country.
On "Fox & Friends" Wednesday morning Trump said that children are "virtually immune" from contracting the coronavirus, which is false.
"It doesn't have an impact on them," Trump told the Fox News morning team. "And I've watched some doctors say they're 'totally immune,' I don't know I hate to use the word 'totally,' the news will say, 'Oh, he made the word totally and he shouldn't have used that word.' But the fact is they are virtually immune from this problem, and we have to open our schools."
How gene editing a person’s brain cells could be used to curb the opioid epidemic
Even as the COVID-19 pandemic cripples the economy and kills hundreds of people each day, there is another epidemic that continues to kill tens of thousands of people each year through opioid drug overdose.
Opioid analgesic drugs, like morphine and oxycodone, are the classic double-edged swords. They are the very best drugs to stop severe pain but also the class of drugs most likely to kill the person taking them.In a recent journal article, I outlined how a combination of state-of-the-art molecular techniques, such as CRISPR gene editing and brain microinjection methods, could be used to blunt one edge of the sword and make opioid drugs safer.
Historian who predicted Trump’s upset 2016 win now says he’s going to crash and burn in 2020
Allan Lichtman, a political historian who teaches at American University in Washington, D.C., became famous for correctly predicting President Donald Trump's upset win four years ago.
But in a new interview with The New York Times, Lichtman makes the case that Trump appears very unlikely to win a second term as the country has been racked for months by the coronavirus pandemic, high unemployment, and civil unrest.